PFKM
Basic information
Region (hg38): 12:48105139-48146404
Previous symbols: [ "PFKX" ]
Links
Phenotypes
GenCC
Source:
- glycogen storage disease VII (Strong), mode of inheritance: AR
- glycogen storage disease VII (Definitive), mode of inheritance: AR
- glycogen storage disease VII (Strong), mode of inheritance: AR
- glycogen storage disease VII (Strong), mode of inheritance: AR
- glycogen storage disease VII (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Glycogen storage disease VII | AR | Cardiovascular; Musculoskeletal; Renal | There is a wide range of types and severity, but avoidance of excessive exercise may be beneficial in order to avoid renal sequale; Surveillance for cardiovascular complications (eg, cardiac hypertrophy) may allow early detection and treatment | Biochemical; Cardiovascular; Gastrointestinal; Hematologic; Musculoskeletal; Ophthalmologic; Renal | 14339001; 4228297; 4228753; 4258222; 6444532; 6444721; 6943439; 6220601; 2945125; 2960695; 2140573; 1533013; 8444874; 8037209; 7513946; 7550225; 7479776; 8889589; 9389749; 22133655; 22364848 |
ClinVar
This is a list of variants' phenotypes submitted to
- Glycogen_storage_disease,_type_VII (888 variants)
- not_provided (97 variants)
- Inborn_genetic_diseases (69 variants)
- not_specified (28 variants)
- PFKM-related_disorder (19 variants)
- Glycogen_storage_disease (1 variants)
- Peroxisomal_biogenesis_disorder_3b (1 variants)
- Rhabdomyolysis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PFKM gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000289.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 312 | 321 | ||||
| missense | 212 | 229 | ||||
| nonsense | 20 | 26 | ||||
| start loss | 0 | |||||
| frameshift | 20 | 40 | 61 | |||
| splice donor/acceptor (+/-2bp) | 33 | 38 | ||||
| Total | 32 | 103 | 221 | 318 | 1 |
Highest pathogenic variant AF is 0.00007282125
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PFKM | protein_coding | protein_coding | ENST00000340802 | 24 | 41266 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.76e-18 | 0.412 | 125612 | 0 | 136 | 125748 | 0.000541 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.36 | 334 | 479 | 0.697 | 0.0000285 | 5598 |
| Missense in Polyphen | 107 | 190.53 | 0.56158 | 2254 | ||
| Synonymous | 1.14 | 153 | 172 | 0.890 | 0.00000999 | 1673 |
| Loss of Function | 1.71 | 34 | 46.6 | 0.730 | 0.00000273 | 514 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000427 | 0.000427 |
| Ashkenazi Jewish | 0.00466 | 0.00467 |
| East Asian | 0.000435 | 0.000435 |
| Finnish | 0.000647 | 0.000647 |
| European (Non-Finnish) | 0.000434 | 0.000413 |
| Middle Eastern | 0.000435 | 0.000435 |
| South Asian | 0.000196 | 0.000196 |
| Other | 0.000978 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.;
- Disease
- DISEASE: Glycogen storage disease 7 (GSD7) [MIM:232800]: A metabolic disorder characterized by exercise intolerance with associated nausea and vomiting, muscle cramping, exertional myopathy and compensated hemolysis. Short bursts of intense activity are particularly difficult. Severe muscle cramps and myoglobinuria develop after vigorous exercise. {ECO:0000269|PubMed:22133655, ECO:0000269|PubMed:24427140, ECO:0000269|PubMed:7513946, ECO:0000269|PubMed:7825568, ECO:0000269|PubMed:8889589}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);Central carbon metabolism in cancer - Homo sapiens (human);RNA degradation - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Pentose phosphate pathway - Homo sapiens (human);Glycolysis;Glycogenosis, Type VII. Tarui disease;Fanconi-bickel syndrome;Pathways in clear cell renal cell carcinoma;Insulin Signaling;Glycolysis and Gluconeogenesis;phosphoinositides and their downstream targets;Metabolism of carbohydrates;Glycolysis Gluconeogenesis;Glycolysis and Gluconeogenesis;Metabolism;Pentose phosphate cycle;Glycolysis;Galactose metabolism;glycolysis;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Glucose metabolism;Validated targets of C-MYC transcriptional activation
(Consensus)
Recessive Scores
- pRec
- 0.784
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.57
Haploinsufficiency Scores
- pHI
- 0.259
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.560
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Pfkm
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; muscle phenotype;
Gene ontology
- Biological process
- glycogen catabolic process;fructose 6-phosphate metabolic process;glucose catabolic process;glycolytic process;fructose 1,6-bisphosphate metabolic process;positive regulation of insulin secretion;glucose homeostasis;positive regulation of transcription by RNA polymerase II;muscle cell cellular homeostasis;carbohydrate phosphorylation;protein complex oligomerization;glycolytic process through fructose-6-phosphate;canonical glycolysis;glycolysis from storage polysaccharide through glucose-1-phosphate
- Cellular component
- nucleus;cytosol;6-phosphofructokinase complex;apical plasma membrane;sperm principal piece
- Molecular function
- 6-phosphofructokinase activity;protein binding;ATP binding;protein C-terminus binding;AMP binding;kinase binding;identical protein binding;protein homodimerization activity;metal ion binding;monosaccharide binding;fructose binding;fructose-6-phosphate binding